Key result
Daily bedside echodynamics optimizes eosinophilic myocarditis therapy, avoiding invasive endomyocardial biopsy.
Why the study?
Daily bedside evaluation of advanced echographic parameters allows therapeutic tailoring across multiple clinical scenarios.
Case Report (n=1)
Daily bedside echodynamic evaluation allows for accurate therapeutic optimization in eosinophilic myocarditis, supporting conservative management without invasive endomyocardial biopsy in asymptomatic patients.
Answers are grounded in this paper and cite their sources.
May support biopsy-sparing hemodynamic guidance in eosinophilic myocarditis; leaves open need for prospective validation before broader adoption.
Introduction Daily bed–side evaluation of echographic advanced parameters allows therapeutic tailoring in multiple scenarios. Case Presentation A 63–year–old woman with no cardiac–related symptoms was admitted to the emergency department because of lower limbs paresthesias. The presence of significant peripheral hypereosinophilia and the results of the chest CT–scan were coherent with the suspect of eosinophilic pneumonia. The ECG showed diffuse ST–segment depression and hsTnI and NT–proBNP were elevated. The echocardiography revealed a diffusely–hypokinetic small–sized left ventricle (LVOT VTI 10 cm, EF 35%), no signs of suboptimal ventriculo–arterial coupling (VAC 1.2), severe functional mitral regurgitation, elevation of left ventricular filling pressures (E/A 1, E wave 56 cm/s, IVRT 60 ms, Vp 40 cm/s), normal indexes of right ventricular systolic function with signs of impaired relaxation (tricuspid E/A 1.2, E/e’ 5.5, presence of pre–systolic RVOT A–wave), moderate tricuspid regurgitation with elevated pulmonary pressures (ePASP 40 mmHg), no splanchnic congestion (normal suvrahepatic vein flow, portal vein pulsatility index ‹ 30%, renal vein stasis index 0) and no splanchnic hypoperfusion (renal resistive index 0.4). Endovenous diuretic therapy was started, without any vasodilator nor inotrope. A coronary CT–angiography ruled out obstructive CAD. The clinical suspect of eosinophilic myocarditis was raised and steroid therapy was started, without performing an invasive endomyocardial biopsy (EMB). The patient had an improvement in terms of anterograde cardiac output and filling pressures, with reduction of MR, TR and estimated pulmonary pressures; weight–adjusted low molecular weight heparin was also started because of left ventricular thrombus. A cardiac magnetic resonance was finally performed, with findings coherent with the hypothesis of eosinophilic myocarditis. Conclusion in this case, two main aspects can be elucidated. The first insight is related to not performing an EMB, according to the 2024 ACC Expert Consensus on Myocarditis: the patient was classified as a stage B (asymptomatic) myocarditis, with an unfavourable estimated risk–benefit ratio. The second insight is related to the role of echodynamics in assessing the need for vasodilator, inotropic and diuretic therapy, especially in a scenario in which diastolic dysfunction plays a major role: daily evaluation allowed an accurate therapeutic optimization.
No takes yet. Share an insight, caveat, or question.
Cucchi et al. (2026) conducted a case report in Eosinophilic myocarditis (n=1). Echodynamics-guided therapy was evaluated. Daily bedside echodynamics allowed accurate therapeutic optimization in a 63-year-old woman with eosinophilic myocarditis, avoiding the need for an invasive endomyocardial biopsy.
Synapse has enriched 10 related papers. Consider them for comparative context: